Zobrazeno 1 - 7
of 7
pro vyhledávání: '"K Miraz Rahman"'
Autor:
Sevda T. Boyanova, Ethlyn Lloyd-Morris, Christopher Corpe, K. Miraz Rahman, Doaa B. Farag, Lee K. Page, Hao Wang, Alice L. Fleckney, Ariana Gatt, Claire Troakes, Gema Vizcay- Barrena, Roland Fleck, Suzanne J. Reeves, Sarah A. Thomas
Blood-brain barrier (BBB) dysfunction may be involved in the increased sensitivity of Alzheimer’s disease (AD) patients to antipsychotics, including amisulpride. Studies indicate that antipsychotics interact with facilitated glucose transporters (G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd0cf121178726ba9009d5c125bea7cf
https://doi.org/10.1101/2023.05.15.540749
https://doi.org/10.1101/2023.05.15.540749
Autor:
Roland A. Fleck, Suzanne Reeves, Hao Wang, K Miraz Rahman, Sarah A. Thomas, Doaa B. Farag, Sevda Tomova Boyanova, Alice L. Fleckney, Ariana Gatt, Gema Vizcay-Barrena
Publikováno v:
Alzheimer's & Dementia. 16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84c6441836f1ac5c99cd46515deba05a
https://doi.org/10.1002/alz.047395
https://doi.org/10.1002/alz.047395
Autor:
Paul J. M. Jackson, Julia Mantaj, Patricia A. Cooper, Schopperle William Michael, Yawen Ju, K Miraz Rahman, Keith R. Fox, David E. Thurston, Steven D. Shnyder, George Procopiou, Francesco Cascio, Paolo Andriollo, David B. Corcoran, Nicolas Veillard, Ilona Pysz, Tan Edwin Saavedra
Publikováno v:
ResearcherID
Although four ADCs have been approved and over sixty others are in development, the majority contain payloads belonging to two classes; tubulin inhibitors and DNA cross-linkers. Challenges in the development of ADCs include managing off-target toxici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ae2e1b2233a9595209e66a02327c8f4
https://doi.org/10.1158/1538-7445.am2018-736
https://doi.org/10.1158/1538-7445.am2018-736
Autor:
Nicolas Veillard, David E. Thurston, Julia Mantaj, K Miraz Rahman, George Procopiou, Paul J. M. Jackson
Publikováno v:
Cancer Research. 76:4779-4779
The pyrrolobenzodiazepines (PBDs) are a class of naturally occurring and synthetic DNA minor-groove binding agents. They covalently bind to the C2-amino group of guanines, and can form mono-alkylated adducts and cross-links depending on the structure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3957de63113f445e4fc1a0fad76da63
https://doi.org/10.1158/1538-7445.am2016-4779
https://doi.org/10.1158/1538-7445.am2016-4779
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lewis T; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, UK., Corcoran DB; School of Cancer and Pharmaceutical Science, King College London, UK., Thurston DE; School of Cancer and Pharmaceutical Science, King College London, UK., Giles PJ; Cardiff University School of Medicine, Heath Park, Cardiff, UK., Ashelford K; Cardiff University School of Medicine, Heath Park, Cardiff, UK., Walsby EJ; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, UK., Fegan CD; Division of Cancer and Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, UK., Pepper AGS; Brighton and Sussex Medical School, University of Sussex, Brighton, UK., Miraz Rahman K; School of Cancer and Pharmaceutical Science, King College London, UK., Pepper C; Brighton and Sussex Medical School, University of Sussex, Brighton, UK.
Publikováno v:
Haematologica [Haematologica] 2021 Apr 01; Vol. 106 (4), pp. 958-967. Date of Electronic Publication: 2021 Apr 01.